Prospective Evaluation of Ruxolitinib Efficacy for CNL/aCML Patients with Mutation of CSF3R
You are being asked to take part in this study because you have chronic neutrophilic leukemia (CNL) or atypical chronic myeloid leukemia (aCML). The goal of this clinical research study is to learn about the effects, good and/or bad, ruxolitinib has on patients with CNL or aCML. The safety of this drug will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 05/05/2015
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: